NCT00576394View on ClinicalTrials.gov

Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Glycemic Control
Interventions
DRUG

IV Insulin drip

IV insulin drip at 100units insulin in 100ml saline designed to keep blood glucose between 120-180mg/dl

DRUG

Insulin

IV insulin drip to keep serum glucose between 80-120mg/dl.

Trial Locations (1)

02118

Boston Medical Center, Boston

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

American Heart Association

OTHER

NCT00576394 - Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients | Biotech Hunter | Biotech Hunter